# Naproxen Sodium

NDC: 59726-751
Generic name: Naproxen Sodium
Labeler / Manufacturer: P & L Development, LLC
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20201204
Marketing ended: 20261231
FDA application: ANDA202807

## Active ingredients

- NAPROXEN SODIUM: 220 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59726-751"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59726-751
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3bd60171-c073-441a-8d59-c85efee69e07